Where's the Promise of Biotech? Featuring Peter Kolchinsky

FEG Insight Bridge

Content provided by FEG Investment Advisors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by FEG Investment Advisors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

3M ago 39:04

MP3•Episode home

In this episode of FEG’s Insight Bridge Podcast, Greg Dowling speaks with Peter Kolchinsky, Managing Partner at RA Capital. Together they delve into the drivers and details of today’s biotech industry, how to foster innovation and why Peter is optimistic about biotech’s ability to address autoimmune disorders. Peter shares RA Capital’s investment approach, which emphasizes patience, rigor and selectiveness across healthcare and life science sectors.

You can find every episode of FEG Insight Bridge podcasts in one place and sign up to receive our other publications here.

Chapters

1. Podcast Introduction (00:00:00)

2. Introduction to RA Capital (00:01:17)

3. Inspiration for Biotech Investing (00:02:13)

4. Today's Biotech Opportunity (00:05:28)

5. Benefits of Active Management (00:07:53)

6. Defining the Biotech Investment Universe (00:09:23)

7. As a Sector Specialist, How Do You Look at Biotech Companies Differently? (00:10:35)

8. Big Pharma's Impact on Biotech M&A (00:14:05)

9. What is Tech Atlas? (00:19:14)

10. The Tech Atlas Process in Action (00:23:04)

11. How Federal Policy is Shaping Healthcare Regulation and Drug Approvals (00:26:36)

12. Outlook and Why RA Capital Remains Optimistic (00:30:55)

13. Biotech Book Recommendation and Peter's Fun Fact (00:34:41)

64 episodes

#Trading #Business #FEG Investment Advisors #Investing #Institutional Investments #Global Investing #Philanthropy #Financial Markets #Finance #Asset Class Commentary #Money Management